Tantangan dan Strategi Manajemen Pasien Tuberculosis di Negara Berkembang Selama Masa Pandemi COVID-19 : Literature Review
Challlenges and Strategies of Tuberculosis Patient Management in Developing Countries Amidst Covid-19 Pandemic : Literature Review
Abstract
Latar Belakang: Penyakit Tuberculosis masih menjadi masalah terutama di negara berkembang. Dengan manajemen yang tepat dapat mengontrol insidensi kasus dan penularan TB. Disrupsi pada salah satu tahapan manajemen karena pandemi COVID-19 berpotensi mempengaruhi tahapan penanganan TB lainnya.
Tujuan: Untuk mengetahui tantangan pada manajemen pasien TB di negara berkembang selama masa pandemi dan rekomendasi strategi yang efektif dalam mengatasi tantangan tersebut.
Metode: Pencarian literatur secara sistematis dengan protokol PRISMA, menggunakan kata kunci pada 6 database online selama tahun 2020-2022. Penilaian kualitas studi untuk mendapatkan studi terpilih menggunakan daftar tilik JBI critical appraisal.
Hasil: Didapatkan 10 studi terpilih dengan hasil yaitu tantangan manajemen TB di negara berkembang selama pandemi antara lain keterbatasan sumber daya, gangguan kontinuitas pengobatan, penurunan notifikasi kasus baru, kesulitan mengakses fasilitas kesehatan, adanya stigmatisasi masyarakat tentang pasien TB dan COVID-19, misdiagnosis TB dengan COVID-19, penurunan cakupan vaksinasi BCG anak dan peningkatan risiko transmisi TB.
Kesimpulan: Tantangan terbesar manajemen TB di negara berkembang selama pandemi adalah keterbatasan sumber daya dan gangguan kontinuitas pengobatan, sebagai akibat penerapan kebijakan lockdown. Strategi yang direkomendasikan berupa inovasi pada layanan TB yang sudah ada dengan kolaborasi lintas sektoral, perubahan metode pemberian OAT, peningkatan edukasi dan optimalisasi pemanfaatan media virtual.
References
Alene KA, Wangdi K, Clements ACA. Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview. Trop Med Infect Dis. 2020;5(3).
Jain VK, Iyengar KP, Samy DA, Vaishya R. Tuberculosis in the era of COVID-19 in India. Diabetes Metab Syndr Clin Res Rev. 2020 Sep;14(5):1439–43.
Marimuthu Y, Nagappa B, Sharma N, Basu S, Chopra KK. COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India. Indian J Tuberc. 2020;67(2):177–81.
WHO. Global tuberculosis report 2021. internet. 2021.
Kanto S, Tyagi R. The impact of COVID-19 on tuberculosis: challenges and opportunities. Ther Adv Infect Dis. 2021 Jan;8:20499361211016972.
Malik YS, Ansari MI, Ganesh B. BCG vaccine: a hope to control COVID-19 pandemic amid crisis. Hum Vaccines Immunother. 2020;16(12):2954–62.
Kyu HH, Maddison ER, Henry NJ, Ledesma JR. Global, regional, and national burden of tuberculosis, 1990-2016: Results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018;18(12):1329–49.
Dlangalala T, Musekiwa A, Brits A, Maluleke K. Evidence of tb services at primary healthcare level during covid-19: A scoping review. Diagnostics. 2021;11(12).
WHO. Question and answer Coronavirus. internet. 2020.
DL EF, Nasution RD. Strategi Pemerintah Dalam Pengelolaan Masa Transisi Di Era New Normal. Pros Ilmu Pemerintah. 2022;137–52.
Moynihan R, Sanders S, Michaleff ZA. Impact of COVID-19 pandemic on utilisation of healthcare services: A systematic review. BMJ Open. 2021;11(3):11–7.
Cilloni L, Fu H, Vesga JF, Dowdy D. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28(March):100603.
Tale S, Meitei Soibam P. Care of tuberculosis patients in the times of COVID-19. Indian J Tuberc. 2021 Apr;68(2):285–6.
JBI. Critical Appraisal Tools. University of Adelaide.
Togun T, Kampmann B, Stoker NG, Lipman M. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob. 2020;19(1).
Bouaddi O, Hasan MM, Sahito AM. Tuberculosis in the middle of COVID-19 in Morocco: efforts, challenges and recommendations. Trop Med Health. 2021;49(1).
Chawla D, Wagh P, Ali S. Impact of COVID 19 pandemic on tuerculosis. Indian J Forensic Med Toxicol. 2020;14(4):6807–10.
Rajindra R, Anggareni RN, Yani A, Akkas N. Economic Recovery in the Aftermath of Earthquake, Tsunami, and Liquefaction disaster during the COVID 19 Pandemic Situation. J Talent Dev Excell. 2020;12(1):2759–66.
Caren GJ, Iskandar D, Pitaloka DAE, Abdulah R, Suwantika AA. COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia. J Multidiscip Healthc. 2022;15:175–83.
Visca D, Tiberi S, Pontali E, Spanevello A, Migliori GB. Tuberculosis in the time of COVID-19: Quality of life and digital innovation. Eur Respir J. 2020;56(2).
Zimmer AJ, Heitkamp P, Malar J. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective. J Clin Tuberc Other Mycobact Dis. 2021;24.
Hasan T, Nguyen VN, Nguyen HB, Nguyen TA, Le HTT, Pham CD, et al. Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020. Emerg Infect Dis. 2022;28(3):684–92.
Ravenscroft L, Kettle S, Persian R, Ruda S. Video-observed therapy and medication adherence for tuberculosis patients: Randomised controlled trial in Moldova. Eur Respir J. 2020;56(2).
Awan HA, Sahito AM, Sukaina M, Khatri G, Waheed S, Sohail F, et al. Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems. Epidemiol Infect. 2022;150.
Rai DK, Kumar R, Pandey SK. Problems faced by tuberculosis patients during COVID-19 pandemic: Urgent need to intervene. Indian J Tuberc. 2020;67(4):S173–4.
Di Gennaro F, Gualano G, Timelli L, Vittozzi P, Di Bari V. Increase in tuberculosis diagnostic delay during first wave of the covidâ€19 pandemic: Data from an Italian infectious disease referral hospital. Antibiotics. 2021;10(3):1–10.
Khan MS, Rego S, Rajal JB, Bond V, Fatima RK. Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries. PLoS One. 2021;16(2 February 2021).
Aznar ML, Espinosa-Pereiro J, Saborit N. Impact of the COVID-19 pandemic on tuberculosis management in Spain. Int J Infect Dis. 2021;108:300–5.
Yang J, Kwon Y, Kim J, Jang Y, Han J, Kim D, et al. Delays in the diagnosis and treatment of tuberculosis during the COVID-19 outbreak in the Republic of Korea in 2020. Osong Public Heal Res Perspect. 2021;12(5):293–303.
Chandir S, Siddiqi DA, Mehmood M. Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data. Vaccine. 2020;38(45):7146–55.
McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG. The impact of COVID-19 on TB: A review of the data. Int J Tuberc Lung Dis. 2021;25(6):436–46.
Arentz M, Ma J, Zheng P, Vos T, Murray CJL, Kyu HH. The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India. BMC Infect Dis. 2022;22(1).
Hani C, Academic B, Mother RM. Trends in paediatric tuberculosis diagnoses in two South African hospitals early in the COVID-19 pandemic. South African Med J. 2020;110(12):1149–50.
Mosconi C, Proia V, Lancorai A, Gentile L. The impact of COVID-19 pandemic on TB cases and health care workers. The experience of tor vergata university hospital Rome, Italy. Acta Medica Mediterr. 2021;37(6):3215–9.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
